The minister was responding to a question, referring to the report of the Spanish Agency of Medicines in recognizing that the pill could cause ectopic pregnancies (those that fall outside the uterus, usually in the fallopian tubes) and has "a potential risk onset of venous thromboembolism.

With regard to drug safety, ministry sources explained that the Agency report speaks only of a "potential risk" without having recorded "a single case of venous thromboembolism in clinical trials, so the conclusion is that the drug is safe. " "Prior to its sale without a prescription already on the market about 500,000 doses per year have been described in Spain without any risk to any woman," he said during his appearance Jimenez.

Moreover, the National Association of Pharmaceutical Specialties Advertising (Anefp), through its director general, Rafael Garcia Gutierrez, expressed its surprise that this product is dispensed without prescription, which, in its view, constitutes " against law '. He said, "no drug is described in Spain as non-prescription if not demonstrate a greater safety profile that is read the package insert for the pill", a clear allusion to the questions raised by such security in view of the effects described by the Agency of Medicines.

Health professionals generally believe that the morning after pill is a product with contraindications of importance and therefore should be re-dispensed only by prescription, or given for free in health centers under the supervision of a physician.

Meanwhile, more than 3,500 pharmacists have already demanded the return of drug to the consultations and the Council of Pharmacists withdraw the brochure on health risks sent. In many cases there is abusive and irresponsible consumption, difficult to assess and that can cause serious health problems.